Hypertrophic Cardiomyopathy with Unusual Extensive Scarring Pattern: Danon Disease
References
- Maron BJ, Roberts WC, Arad M, Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy. JAMA. 2009 Mar 25; 301( 12): 1253– 9.
- Silva C, Moon JC, Elkington AG, John AS, Mohiaddin RH, Pennell DJ. Myocardial late gadolinium enhancement in specific cardiomyopathies by cardiovascular magnetic resonance: a preliminary experience. J Cardiovasc Med (Hagerstown). 2007 Dec; 8( 12): 1076– 9.
- Maron BJ, Roberts WC, Arad M, Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy. JAMA. 2009; 301( 12): 1253– 9.
- Danon MJ, Oh SJ, DiMauro S, Lysosomal glycogen storage disease with normal acid maltase. Neurology. 1981 Jan; 31( 1): 51– 7.
- Sugie K, Yamamoto A, Murayama K, Clinicopathological features of genetically confirmed Danon disease. Neurology. 2002 Jun 25; 58( 12): 1773– 8.
- Arad M, Maron BJ, Gorham JM, Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med. 2005 Jan 27; 352( 4): 362– 72.
- Dougu N, Joho S, Shan L, Novel LAMP-2 mutation in a family with Danon disease presenting with hypertrophic cardiomyopathy. Circ J. 2009; 73: 376– 80.
DOI: https://doi.org/10.14797/mdcj-12-4-227 | Journal eISSN: 1947-6108
Language: English
Page range: 227 - 229
Published on: Oct 1, 2016
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
© 2016 Dan D. Le, Paulino Alvarez, Roberto Barrios, Michael Arriaga, Mariyam Cherry, Dipan Shah, C. Huie Lin, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.